NPS Pharmaceuticals (NPSP) Mildly Higher after FDA Backing
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Jefferies Raises NPS Pharmaceuticals (NPSP) Target to $15 after FDA Panel Backing
October 17, 2012 7:19 AM EDTJefferies lifted its price target on Buy-rated NPS Pharmaceuticals Inc. (NASDAQ: NPSP) from $13 to $15 following FDA panel backing of Gattex.
"As expected, FDA's AdComm panel voted for recommending approval of Gattex unanimously. Panel also voted favorably on NPSP's proposed REMS (10-1), supporting likely timely... More
NPS Pharmaceuticals (NPSP) to resume trading at 4:20PM
October 16, 2012 4:19 PM EDTNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) to resume trading at 4:20PM after FDA panel backing for Gattex.... More
FDA panel backs NPS Pharmaceuticals (NPSP) Gattex
October 16, 2012 3:13 PM EDTFDA panel backs NPS Pharmaceuticals' (NASDAQ: NPSP) Gattex
(NOTE: shares have been halted all day in anticipation of the adcom)... More
FDA Says NPS Pharma's (NPSP) Gattex has 'Clinically Meaningful' Benefit
October 16, 2012 2:14 PM EDTNPS Pharmaceuticals' (NASDAQ: NPSP) Gattex had clinically meaningful benefit for short bowel, according to the FDA.... More
NPS Pharma (NPSP) Halted Ahead of FDA Committee Meeting for Gattex
October 16, 2012 7:11 AM EDTNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) shares were halted ahead of the Gastrointestinal Drugs Advisory Committee meeting to review Gattex (teduglutide). The meeting is scheduled for today, October 16, 2012 at 8:00 a.m. ET.
The briefing materials can be found on the FDA website at... More
NPS Pharmaceuticals, Inc. (NPSP) halted, news pending
October 16, 2012 7:01 AM EDTNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) halted, news pending... More
